Ian N Bruce

1984–2025 年に発表

別表記
Ian N. Bruce
176
論文数
30,204
被引用数
89
h 指数
171
i10 指数

被引用数

Ian N Bruce の年別被引用数1984 年: 被引用 2 件1999 年: 被引用 1 件2000 年: 被引用 7 件2001 年: 被引用 8 件2002 年: 被引用 8 件2003 年: 被引用 21 件2004 年: 被引用 18 件2005 年: 被引用 44 件2006 年: 被引用 43 件2007 年: 被引用 70 件2008 年: 被引用 104 件2009 年: 被引用 142 件2010 年: 被引用 110 件2011 年: 被引用 150 件2012 年: 被引用 144 件2013 年: 被引用 153 件2014 年: 被引用 178 件2015 年: 被引用 180 件2016 年: 被引用 215 件2017 年: 被引用 201 件2018 年: 被引用 223 件2019 年: 被引用 868 件2020 年: 被引用 1,074 件2021 年: 被引用 1,211 件2022 年: 被引用 999 件2023 年: 被引用 761 件2024 年: 被引用 1,372 件2025 年: 被引用 696 件2026 年: 被引用 14 件1985〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,120 件、この内訳の 18.7%イギリス: 引用元論文 1,066 件、この内訳の 9.4%中国: 引用元論文 762 件、この内訳の 6.7%イタリア: 引用元論文 641 件、この内訳の 5.7%カナダ: 引用元論文 502 件、この内訳の 4.4%ドイツ: 引用元論文 487 件、この内訳の 4.3%フランス: 引用元論文 455 件、この内訳の 4%スウェーデン: 引用元論文 400 件、この内訳の 3.5%スペイン: 引用元論文 396 件、この内訳の 3.5%オランダ: 引用元論文 357 件、この内訳の 3.2%日本: 引用元論文 350 件、この内訳の 3.1%オーストラリア: 引用元論文 294 件、この内訳の 2.6%
0%18.7%その他 30.9%

分野

  • Medicine75.4%
  • Immunology and Microbiology10.6%
  • Biochemistry, Genetics and Molecular Biology7.9%
  • Neuroscience1.5%
  • Computer Science1%
  • Engineering0.5%
  • その他3.1%

トピック

  • Systemic Lupus Erythematosus Research17.7%
  • Rheumatoid Arthritis Research and Therapies6.8%
  • T-cell and B-cell Immunology3.5%
  • Systemic Sclerosis and Related Diseases2.9%
  • Monoclonal and Polyclonal Antibodies Research2.8%
  • Atherosclerosis and Cardiovascular Diseases2.6%
  • その他63.7%

共著者

全論文

検索で開く
  1. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mary Anne Dooley, Ronald van Vollenhoven, Ellen M. Ginzler, Thomas Stoll, Christine Peschken, Joseph L. Jorizzo, Jeffrey P. Callen, S. Sam Lim, Barri J. Fessler, Murat İnanç, Diane L. Kamen, Anisur Rahman, Kristján Steinsson, Andrew G. Franks, Lisa Sigler, Suhail Hameed, Hong Fang, Ngoc Minh Pham, Robin L. Brey, Michael H. Weisman, Gerald McGwin, Laurence S. Magder - Arthritis & Rheumatism 2012 被引用: 5,295

  2. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Yoshiya Tanaka, Maria G. Tektonidou, Y K Onno Teng, Anǵela Tincani, Edward M Vital, Ronald van Vollenhoven, Chris Wincup, George Βertsias, Dimitrios T. Boumpas - Annals of the Rheumatic Diseases 2023 被引用: 933

  3. Trial of Anifrolumab in Active Systemic Lupus Erythematosus

    著者: , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 1,326

  4. 2021 DORIS definition of remission in SLE: final recommendations from an international task force

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raquel Faria, Rebecca S. B. Fischer, Ruth Fritsch‐Stork, Murat İnanç, Søren Jacobsen, David Jayne, Annegret Kuhn, Bernadette van Leeuw, Maarten Limper, Xavier Mariette, Sandra Navarra, Mandana Nikpour, Marzena Olesińska, Guillermo Pons‐Estel, Juanita Romero‐Díaz, Blanca Rubio, Y Schoenfeld, Eloísa Bonfá, Josef S Smolen, Y K Onno Teng, Anǵela Tincani, Michel Tsang-A-Sjoe, Carlos Vasconcelos, Anne Voss, Victoria P. Werth, Elena Zakharhova, Cynthia Aranow - Lupus Science & Medicine 2021 被引用: 349

  5. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 被引用: 375

  6. Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial

    著者: , , , , , , , , , , , , - The Lancet Rheumatology 2019 被引用: 482

  7. The frequency and outcome of lupus nephritis: results from an international inception cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Asad Zoma, Manuel Ramos‐Casals, Guillermo Ruiz‐Irastorza, S. Sam Lim, Thomas Stoll, Murat İnanç, Kenneth Kalunian, Diane L. Kamen, Peter J. Maddison, Christine Peschken, Søren Jacobsen, Anca Askanase, Chris Theriault, Kara Thompson, Vernon T. Farewell - Lara D. Veeken 2015 被引用: 632

  8. Clinical Applications of Machine Learning Algorithms: Beyond the Black Box

    著者: , , , , , , - BMJ 2019 被引用: 442

  9. A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus

    著者: , , , , , , , , , , , , , , - Arthritis & Rheumatology 2022 被引用: 152

  10. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jozef Rovenský, Josef S Smolen, Carlos Vasconcelos, Alexandre E. Voskuyl, Anne Voss, Elena Zakharova, Asad Zoma, Matthias Schneider - Annals of the Rheumatic Diseases 2014 被引用: 727

  11. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)

    著者: , , , , , , , , , , , , , , - The Lancet 2023 被引用: 165

  12. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus

    著者: , , , , , , , , , , , , , , , - Lara D. Veeken 2005 被引用: 635

  13. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

    著者: , , , , , , , , , , , , , , , , - The Lancet 2018 被引用: 513

  14. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Damjan Vukcevic, Mohammed Akil, Jonathan Barratt, Neil Basu, Adam S. Butterworth, Ian N Bruce, Michael Clarkson, Niall Conlon, Bhaskar Dasgupta, Timothy Doulton, Georgina Espígol‐Frigolé, Oliver Floßmann, Armando Gabrielli, Jolanta Gąsior, Gina Gregorini, Giuseppe Guida, José Hernández‐Rodríguez, Zdenka Hrušková, Amy W. Hudson, Ann Knight, Peter Lanyon, Raashid Luqmani, Malgorzata Magliano, Angelo A. Manfredi, Christopher Marguerie, Federica Maritati, Chiara Marvisi, Neil McHugh, Eamonn Molloy, Allan Motyer, Chetan Mukhtyar, Leonid Padyukov, Alberto Pesci, Sergio Prieto‐González, Marc Ramentol-Sintas, Petra Reis, Dario Roccatello, Patrizia Rovere‐Querini, Carlo Salvarani, Francesca Santarsia, Roser Solans‐Laqué, Nicole Soranzo, Jo Taylor, Julie Wessels, Jochen Zwerina, Benjamin Terrier, Richard A. Watts, Augusto Vaglio, Julia U. Holle, Chris Wallace, Kenneth G. C. Smith - Nature Communications 2019 被引用: 271

  15. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Véronique Le Guern, Kirsten Lerstrøm, Roger A. Levy, Francinne Machado-Ribeiro, Xavier Mariette, Jamil Missaykeh, Eric F. Morand, Marta Mosca, Murat İnanç, Sandra Navarra, Irmgard Neumann, Marzena Olesińska, Michelle Petri, Anisur Rahman, Ole Petter Rekvig, Jozef Rovenský, Yehuda Shoenfeld, Josef S Smolen, Anǵela Tincani, Murray B. Urowitz, Bernadette van Leeuw, Carlos Vasconcelos, Anne Voss, Victoria P. Werth, Elena Zakharova, Asad Zoma, Matthias Schneider, Michael M. Ward - Annals of the Rheumatic Diseases 2016 被引用: 357

  16. Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials

    著者: , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 被引用: 142

  17. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Meggan Mackay, Manuel Ramos‐Casals, Ronald van Vollenhoven, Kenneth Kalunian, Guillermo Ruiz‐Irastorza, Sam Lim, Diane L. Kamen, Christine Peschken, Murat İnanç, Murray B. Urowitz - Annals of the Rheumatic Diseases 2014 被引用: 566

  18. Drug-Induced Interstitial Lung Disease: A Systematic Review

    著者: , , , , , , , , , , , , , , - Journal of Clinical Medicine 2018 被引用: 408

  19. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults

    著者: , , , , , , , , , , , , , , , - Lara D. Veeken 2017 被引用: 357

  20. Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guillermo Ruiz‐Irastorza, Sam Lim, Murat İnanç, Kenneth Kalunian, Søren Jacobsen, Christine Peschken, Diane L. Kamen, Anca Askanase, Jill P. Buyon, David Sontag, Karen H. Costenbader - Annals of the Rheumatic Diseases 2023 被引用: 81

  21. Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus

    著者: , , , , , , , , , , , - Lara D. Veeken 2021 被引用: 123

  22. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2010 被引用: 727

  23. Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Héloïse Reumaux, James O’Sullivan, Thierry Walzer, Anne‐Laure Mathieu, Gaëlle Marenne, Thomas Ludwig, Emmanuelle Génin, Jamie M. Ellingford, Brigitte Bader-Meunier, Tracy A. Briggs, Michael W. Beresford, Yanick J. Crow, Dominique Campion, Jean‐François Dartigues, Jean‐François Deleuze, Emmanuelle Génin, Jean‐Charles Lambert, Richard Redon, Emma Allain-Launay, Brigitte Bader‐Meunier, Alexandre Bélot, Kenza Bouayed, Stéphane Burtey, Aurélia Carbasse, Stéphane Decramer, V. Despert, O. Fain, Michel Fischbach, Hugues Flodrops, Caroline Galeotti, Eric Hachulla, Yves Hatchuel, J.F. Kleinmann, Isabelle Koné‐Paut, Aurélia Lanteri, I. Lemelle, Hélène Maillard, François Maurier, Ulrich Meinzer, Isabelle Melki, S. Morell‐Dubois, Anne Pagnier, Maryam Piram, Bruno Ranchin, Héloïse Reumaux, Charlotte Samaille, Jean Sibilia, Olivia Weill, Eslam Al-Abadi, Kate Armon, Kathryn Bailey, Michael W. Beresford, Mary Brennan, Coziana Ciurtin, Janet Gardner‐Medwin, Kirsty Haslam, Daniel Hawley, Alice Leahy, Valentina Leone, Devesh Mewar, Rob Moots, Clarissa Pilkington, Athimalaipet V Ramanan, Satyapal Rangaraj, Annie Ratcliffe, Philip Riley, Ethan S Sen, Arani Sridhar, Nick Wilkinson, Fiona Wood - The Lancet Rheumatology 2020 被引用: 92

  24. Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manuel Ramos‐Casals, Kristján Steinsson, Asad Zoma, Anca Askanase, Munther A. Khamashta, Ian N Bruce, Murat İnanç, Michał Abrahamowicz, Sasha Bernatsky - Annals of the Rheumatic Diseases 2021 被引用: 98